Phenotype comparison among individuals with developmental delay/intellectual disability with or without genomic imbalances
- 21 March 2019
- journal article
- research article
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 63 (11) , 1379-1389
Abstract
Background The chromosomal microarray analysis (CMA) is recommended as a first‐tier test for individuals with developmental delay (DD)/intellectual disability (ID) and/or multiple congenital anomalies. However, owing to high costs, this technique is not widely performed for diagnostic purposes in several countries. The aim of this study was to identify clinical features that could favour the hypothesis of genomic imbalances (GIs) in individuals with DD/ID. Methods The sample consisted of 63 individuals, and all of them underwent a detailed evaluation by a clinical geneticist and were investigated by the CMA. They were divided into two groups. Group A composed of 20 individuals with pathogenic copy number variants (CNVs); and group B composed of 43 individuals with normal CMA results or variants of uncertain clinical significance (VUS). Results Pathogenic GIs were found in 20 cases (32%), including 11 individuals with an abnormal karyotype, VUS was found in five individuals (8%) and the results were normal in 38 individuals (60%). Major anomalies were found in 15/20 (75%) individuals in group A against 35/43 (81%) in group B. Dysmorphisms (≥5) were found in 17/20 (85%) in group A and 41/43 (95%) in group B. The most frequent major anomalies detected in group A were congenital heart disease, epilepsy and renal malformation; and in group B, they were malformations of central nervous system, congenital heart disease, microcephaly, epilepsy and hearing impairment. There was no significant statistical difference among the frequencies in groups A and B. Conclusions Evidences point that every individual with DD/ID, with no specific clinical suspicion, should have screening for GIs as a first‐tier test, regardless of the presence or absence of additional major anomalies or dysmorphisms. Future studies with a similar design would be helpful, especially in countries where the access to new technologies is still limited.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2012/51799‐6)
This publication has 28 references indexed in Scilit:
- A recognizable phenotype related to 19p13.12 microdeletionAmerican Journal of Medical Genetics Part A, 2018
- Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genesClinical Genetics, 2017
- New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variantsItalian Journal of Pediatrics, 2016
- The Diagnostic Yield of Array Comparative Genomic Hybridization Is High Regardless of Severity of Intellectual Disability/Developmental Delay in ChildrenJournal of Child Neurology, 2015
- Chromosomal microarrays testing in children with developmental disabilities and congenital anomaliesJornal de Pediatria, 2015
- Predictive diagnostic value for the clinical features accompanying intellectual disability in children with pathogenic copy number variations: a multivariate analysisItalian Journal of Pediatrics, 2014
- Pathogenic or not? Assessing the clinical relevance of copy number variantsClinical Genetics, 2013
- Interpretation of Array Comparative Genome Hybridization Data: A Major ChallengeCytogenetic and Genome Research, 2011
- American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variantsGenetics in Medicine, 2011
- Whole-genome array-CGH screening in undiagnosed syndromic patients: old syndromes revisited and new alterationsCytogenetic and Genome Research, 2006